| Zdroj: |
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 16, no. Suppl. 1, pp. I587-I588 . https://doi.org/10.1093/ecco-jcc/jjab232.807 |
